Woodline Partners’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Woodline Partners’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-150,000	Closed	-$1.48M	–	946
2022 Q3	$1.48M	Hold	150,000	–	–	0.02%	499
2022 Q2	$1.47M	Hold	150,000	–	–	0.02%	479
2022 Q1	$1.47M	Hold	150,000	–	–	0.02%	434
2021 Q4	$1.47M	Hold	150,000	–	–	0.02%	463
2021 Q3	$1.46M	Hold	150,000	–	–	0.02%	464
2021 Q2	$1.45M	Hold	150,000	–	–	0.03%	402
2021 Q1	$1.45M	Buy	+150,000	New	+$1.45M	0.03%	336

Woodline Partners's SHAC Position: Q4 2022 in Review

Woodline Partners sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 150,000 shares — an estimated $1.48M sold.

Woodline Partners first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.48M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Woodline Partners reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Woodline Partners sold 150,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $1.48M.
Woodline Partners first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
Woodline Partners's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $1.48M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.